1.Research progress of transcriptomics and proteomics in schizophrenia.
Xin REN ; Shu Min TAN ; Jia Xiu LIU ; Fei Ling JIANG ; Xiao Bin WEI
Chinese Journal of Preventive Medicine 2023;57(10):1704-1710
Schizophrenia is a severe psychiatric disorder with an unclear etiology and various clinical manifestations. The diagnosis and consequent treatment of schizophrenia mainly rely on clinical symptoms. Multiple risk sites associated with schizophrenia have been identified, yet objective indicators have not been found to facilitate clinical diagnosis and treatment of schizophrenia. The development of omics technology provides different perspectives on the etiology of schizophrenia and make the early identification, diagnosis and treatment of the disorder possible. This article summarizes the prevalence of schizophrenia, reviews the research results and shortcomings of transcriptomics and proteomics, as well as the latest achievements and prospects of multi-omics, aiming to reveal the use of omics in SZ, provide more comprehensive biological evidence to reveal the complex pathogenesis of schizophrenia and provide a theoretical basis for the early identification, accurate diagnosis, disease progression control, and prognosis improvement of schizophrenia.
Humans
;
Proteomics/methods*
;
Transcriptome
;
Schizophrenia/genetics*
2.Advances of peptide-centric data-independent acquisition analysis algorithms and software tools.
Yingying ZHANG ; Kunxian SHU ; Cheng CHANG
Chinese Journal of Biotechnology 2023;39(9):3579-3593
Data-independent acquisition (DIA) is a high-throughput, unbiased mass spectrometry data acquisition method which has good quantitative reproducibility and is friendly to low-abundance proteins. It becomes the preferred choice for clinical proteomic studies especially for large cohort studies in recent years. The mass-spectrometry (MS)/MS spectra generated by DIA is usually heavily mixed with fragment ion information of multiple peptides, which makes the protein identification and quantification more difficult. Currently, DIA data analysis methods fall into two main categories, namely peptide-centric and spectrum-centric. The peptide-centric strategy is more sensitive for identification and more accurate for quantification. Thus, it has become the mainstream strategy for DIA data analysis, which includes four key steps: building a spectral library, extracting ion chromatogram, feature scoring and statistical quality control. This work reviews the peptide-centric DIA data analysis procedure, introduces the corresponding algorithms and software tools, and summarizes the improvements for the existing algorithms. Finally, the future development directions are discussed.
Humans
;
Proteomics/methods*
;
Reproducibility of Results
;
Peptides/chemistry*
;
Software
;
Algorithms
;
Tandem Mass Spectrometry/methods*
;
Proteome/analysis*
3.Proteomic Difference Analysis of Whole Blood and Bloodstains.
Ao HUANG ; Shu-Bo WEN ; Qian-Qian KONG ; Zhen-Min ZHAO ; Xi-Ling LIU
Journal of Forensic Medicine 2023;39(6):549-556
OBJECTIVES:
To study the changes of protein levels in peripheral blood after it dried.
METHODS:
The proteins from whole blood and bloodstains were detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and normalized by the label-free quantification (LFQ) method. The differential proteins were analyzed by using R 4.2.1 software, limma and edgeR package. The analysis of biological function, signaling pathway and subcellular localization for the differential proteins was then performed.
RESULTS:
A total of 623 and 596 proteins were detected in whole blood and bloodstains, respectively, of which 31 were statistically significant in the quantitative results, including 10 up-regulated and 21 down-regulated proteins in bloodstains.
CONCLUSIONS
The protein abundances in whole blood and bloodstains are highly correlated, and the variation of protein abundances may be related to the changes of endogenous and structural proteins in cells. The application of proteomics technology can assist the screening and identification of protein biomarkers, thereby introducing new biomarkers for forensic research.
Chromatography, Liquid/methods*
;
Tandem Mass Spectrometry/methods*
;
Proteomics/methods*
;
Blood Stains
;
Biomarkers
4.Research progress of transcriptomics and proteomics in schizophrenia.
Xin REN ; Shu Min TAN ; Jia Xiu LIU ; Fei Ling JIANG ; Xiao Bin WEI
Chinese Journal of Preventive Medicine 2023;57(10):1704-1710
Schizophrenia is a severe psychiatric disorder with an unclear etiology and various clinical manifestations. The diagnosis and consequent treatment of schizophrenia mainly rely on clinical symptoms. Multiple risk sites associated with schizophrenia have been identified, yet objective indicators have not been found to facilitate clinical diagnosis and treatment of schizophrenia. The development of omics technology provides different perspectives on the etiology of schizophrenia and make the early identification, diagnosis and treatment of the disorder possible. This article summarizes the prevalence of schizophrenia, reviews the research results and shortcomings of transcriptomics and proteomics, as well as the latest achievements and prospects of multi-omics, aiming to reveal the use of omics in SZ, provide more comprehensive biological evidence to reveal the complex pathogenesis of schizophrenia and provide a theoretical basis for the early identification, accurate diagnosis, disease progression control, and prognosis improvement of schizophrenia.
Humans
;
Proteomics/methods*
;
Transcriptome
;
Schizophrenia/genetics*
5.Twenty years in the 21st century: research approaches and techniques in modern system biology for mechanisms of Chinese medicinal processing.
Shu-Chen GUO ; De-Tian LI ; Shi-Kui LIANG ; Wei WU ; Bing YANG ; Liang FENG ; Xiao-Bin JIA
China Journal of Chinese Materia Medica 2022;47(5):1170-1176
Clarifying the mechanisms of Chinese medicinal processing is pivotal to the modernization of Chinese medicine. Research on Chinese medicinal processing gives priority to the mechanisms of the processing in enhancing efficacy, reducing toxicity, and repurposing medicinals. During the past 20 years, scholars have carried out in-depth studies on the mechanisms of Chinese medicinal processing via modern system biology. They mainly focused on the changes of medicinal properties and efficacy caused by processing using techniques of modern pharmacology and molecular biology, spectrum-efficacy correlation, and biophoton emission. However, these techniques fail to reflect the holistic view of traditional Chinese medicine. With the introduction of system biology, multi-omics techno-logies(genomics, transcriptomics, proteomics, and metabolomics) have surged, which have been applied to the research on the mec-hanisms of Chinese medicinal processing. These multi-omics technologies have advantages in the research on holism. This study aims to summarize the research techniques and approaches in system biology for mechanisms of Chinese medicinal processing in the past 20 years and analyze the limitations and advantages of them. It is concluded that the multi-omics techniques of system biology can reconstruct the mechanisms of Chinese medicinal processing. This study provides a new direction for further research on the mechanisms of Chinese medicinal processing.
China
;
Genomics
;
Medicine, Chinese Traditional
;
Metabolomics/methods*
;
Proteomics
6.Advances of chromatogram retention time alignment algorithms in proteomics.
Yi LIU ; Cheng CHANG ; Yunping ZHU
Chinese Journal of Biotechnology 2022;38(3):961-975
Chromatography is a basic process in the current proteomics workflow, and the retention time alignment of the chromatogram is one of the important steps to effectively improve the identification and quantification accuracy. After years of development, a series of algorithms for retention time alignment have been developed. This review summarizes the advances of chromatographic retention time alignment algorithms and tools for proteomics analysis from the perspective of proteomics users, and discusses the development and future application directions.
Algorithms
;
Proteomics/methods*
7.Quantitative proteomics revealed extensive microenvironmental changes after stem cell transplantation in ischemic stroke.
Yao CHEN ; Fahuan SONG ; Mengjiao TU ; Shuang WU ; Xiao HE ; Hao LIU ; Caiyun XU ; Kai ZHANG ; Yuankai ZHU ; Rui ZHOU ; Chentao JIN ; Ping WANG ; Hong ZHANG ; Mei TIAN
Frontiers of Medicine 2022;16(3):429-441
The local microenvironment is essential to stem cell-based therapy for ischemic stroke, and spatiotemporal changes of the microenvironment in the pathological process provide vital clues for understanding the therapeutic mechanisms. However, relevant studies on microenvironmental changes were mainly confined in the acute phase of stroke, and long-term changes remain unclear. This study aimed to investigate the microenvironmental changes in the subacute and chronic phases of ischemic stroke after stem cell transplantation. Herein, induced pluripotent stem cells (iPSCs) and neural stem cells (NSCs) were transplanted into the ischemic brain established by middle cerebral artery occlusion surgery. Positron emission tomography imaging and neurological tests were applied to evaluate the metabolic and neurofunctional alterations of rats transplanted with stem cells. Quantitative proteomics was employed to investigate the protein expression profiles in iPSCs-transplanted brain in the subacute and chronic phases of stroke. Compared with NSCs-transplanted rats, significantly increased glucose metabolism and neurofunctional scores were observed in iPSCs-transplanted rats. Subsequent proteomic data of iPSCs-transplanted rats identified a total of 39 differentially expressed proteins in the subacute and chronic phases, which are involved in various ischemic stroke-related biological processes, including neuronal survival, axonal remodeling, antioxidative stress, and mitochondrial function restoration. Taken together, our study indicated that iPSCs have a positive therapeutic effect in ischemic stroke and emphasized the wide-ranging microenvironmental changes in the subacute and chronic phases.
Animals
;
Cell Differentiation
;
Disease Models, Animal
;
Ischemic Stroke
;
Proteomics
;
Rats
;
Stem Cell Transplantation/methods*
;
Stroke/therapy*
8.Modern research thoughts and methods on bio-active components of TCM formulae.
Yu-Ping TANG ; Ding-Qiao XU ; Shi-Jun YUE ; Yan-Yan CHEN ; Rui-Jia FU ; Xue BAI
Chinese Journal of Natural Medicines (English Ed.) 2022;20(7):481-493
TCM formulae are the important guidances for clinical application of traditional Chinese medicines, which follow the principles of diagnosis and treatment in TCM. Elucidating the bio-active components of TCM formulae is the key to the modernization and internationalization of traditional Chinese medicines. With the rapid development of modern instruments and technology, many new theories, methods and strategies are emerging, which upgrade the research of TCM formulae into a higher level. Only when the medicinal efficacy, bio-active components, function mechanism of TCM formulae are understood, we can guarantee TCM safety and quality control. In this paper, we summarized the latest modern research thoughts and methods on bio-active components of TCM formulae including formula decomposition study, serum pharmacology and serum pharmacochemistry, association analysis, biochromatography, network pharmacology, metabolomics and proteomics, so as to provide reference for the research and development of TCM in the future.
Biological Products
;
Drugs, Chinese Herbal/chemistry*
;
Medicine, Chinese Traditional/methods*
;
Metabolomics
;
Proteomics
9.Multi-omics technology and its applications to life sciences: a review.
Jingfang LIU ; Weilin LI ; Li WANG ; Juan LI ; Erwei LI ; Yuanming LUO
Chinese Journal of Biotechnology 2022;38(10):3581-3593
With technological advances in high-throughput sequencing, high resolution mass-spectrometry, and multi-omics data integrative tools and data repositories, the omics research in life sciences are evolving from single-omics strategy to multi-omics strategy. The research of system biology driven by multi-omics will bring a new paradigm in life sciences. This paper briefly summarizes the development of genomics, epigenomics, transcriptomics, proteomics and metabolomics, highlights the composition and function of multi-omics platforms as well as the applications of multi-omics technology, and prospects future applications of multi-omics in synthetic biology and biomedicine.
Genomics
;
Proteomics/methods*
;
Metabolomics/methods*
;
Epigenomics/methods*
;
Technology
10.Advances in the methods of phosphopeptide enrichment and separation in phosphoproteomic research.
Jiaran LI ; Xiulan CHEN ; Fuquan YANG
Chinese Journal of Biotechnology 2022;38(10):3648-3658
The systematic and in-depth study of phosphoproteome rely on highly reproducible and specific phosphopeptide enrichment methods. At present, a variety of enrichment methods have been developed based on different principles, and these methods often display different selectivity and specificity. It is therefore very important to select the most suitable enrichment method according to different research purposes. This review summarized the phosphopeptide enrichment based on affinity chromatography, immunoprecipitation, chemical derivatization, chromatography and other newly developed methods. The advantages and disadvantages of these methods, as well as the related optimization and improvement strategies, were discussed in detail. In addition, we also briefly summarized the progress of the combination of phosphopeptide enrichment and fractionation methods developed in recent years.
Phosphopeptides/metabolism*
;
Proteomics/methods*
;
Titanium/chemistry*
;
Chromatography, Affinity
;
Proteome
;
Phosphorylation

Result Analysis
Print
Save
E-mail